October 2026
M	T	W	T	F	S	S
	1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Somer Baburek: Endometriosis Enters a New Phase as Science and Awareness Converge

Somer Baburek/LinkedIn

Apr 4, 2026, 05:45

Somer Baburek: Endometriosis Enters a New Phase as Science and Awareness Converge

Somer Baburek, Co-Founder, CEO, President at Hera Biotech, shared a post on LinkedIn:

“Over the past few months, several developments in endometriosis research have pointed to a broader shift in the field.

Taken individually, each is interesting.

Taken together, they suggest something more significant.

We’re beginning to see the early stages of a transformation in how endometriosis is understood, diagnosed, and ultimately treated.

On one hand, recent genomic research is starting to clarify the biological origin of endometriosis lesions, suggesting they may be derived from endometrial tissue.

On the other, the new ACOG guideline reinforces a long-standing reality:

we still lack reliable noninvasive diagnostics, and many patients continue to wait years for answers.

At the same time, awareness of endometriosis has grown significantly, with more patients recognizing symptoms and seeking care earlier than in the past.

Put these pieces together, and a pattern emerges:

the biology is becoming clearer
patient awareness is increasing
but the clinical tools to diagnose disease haven’t kept pace

This is a familiar moment in medicine.

In oncology and infectious disease, major advances didn’t come from a single breakthrough.

They came from building the diagnostic infrastructure that allowed physicians to:

detect disease earlier
classify it more precisely
match patients with the right therapies

Endometriosis may now be approaching a similar inflection point.

As our understanding of the biology deepens – and as new diagnostic approaches emerge – we have an opportunity to fundamentally change how this disease is identified and managed.

For millions of patients who still face years of uncertainty, that shift can’t come soon enough.”

Cadenza Bio shared Somer Baburek’s post on LinkedIn, adding:

“Recent progress in endometriosis research reflects a meaningful shift in how the disease is understood and managed, and we appreciate the perspective shared by Somer Baburek and Hera Biotech. It is encouraging to see strong momentum across the field, with advances in biology, increased patient awareness, and a continued focus on improving diagnostics.”

Stay updated on all scientific advances in the field of fertility with Fertility News.